Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | GAK | O14976 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.35 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2215288 | 0.82 | L3MBTL1 (0.44) | PIK3CAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL2247007 | 0.81 | PIK3CA (0.40) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2247014 | 0.81 | PIK3CA (0.40) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2215329 | 0.80 | ERN1 (0.46) | ALDH1A1MEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL2216045 | 0.80 | ALDH1A1 (0.37) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2217944 | 0.80 | SCN9A (0.43) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2212992 | 0.80 | ERN1 (0.44) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2213470 | 0.80 | CNR2 (0.40) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 | |
| SCHEMBL2215416 | 0.79 | GAK (0.52) | PIK3CAALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL2216042 | 0.78 | GAK (0.41) | PIK3CAPIK3CDPIK3CGALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110178064-A1 | SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL | ASTRAZENECA R&D (SE) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178064-A1 | SPIRO CONDENSED BARBITURIC ACID DERIVATIVES FOR USE AS ANTIBACTERIAL | TBCA, TUBA1A, BROX | PIK3CA 3969/4885PIK3CD 4358/4885PIK3CG 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.